BEVERLY, Mass., June 09, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, Inc. (OTCQB:IPIX) (“the Company”), an emerging biopharmaceutical company, is pleased to announce that the Company’s name and ticker change from Cellceutix Corp. and “CTIX” is effective at the commencement of trading today, June 9, 2017.
Innovation Pharmaceuticals’ management discussed the rationale underscoring the name change as a better reflection of the Company’s mission, along with other corporate developments and a lengthy question and answer session, in a shareholder conference call on June 8, 2017. Investors may listen to a replay of the investor call by:
- dialing 877-481-4010 or 919-882-2331 and using access code #15776 (expires 11 AM EST on June 22, 2017)
- visiting http://www.investorcalendar.com/event/15776 (expires 11 AM EST on September 8, 2017)
The Company wishes to remind shareholders that they are not required to take any action with respect to the name and ticker change.